Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Spatially resolving tumor immune networks at single-cell resolution of ccRCC tumour immune microenvironment

EF 2022-23

Résumé
Kidney cancer contributes to over 430,000 new cases and 179,000 deaths annually worldwide. During later stages of the disease, where cancer spreads from kidney to other vital organs, the disease is mostly incurable. Immunotherapy, which harnesses the host immune system to fight cancer, has contributed to a longer survival time in patients with clear cell kidney cancer (the most common subtype of kidney cancer). However, current immunotherapies are relatively ineffective, as only a minority of patients respond to the treatment and benefit from it. Thus, it is urgent to improve immunotherapies for kidney cancer. The proposed research project aims to profile the immune cell subtypes within retrospective kidney tumor samples by analyzing single-cell RNA sequencing data. In addition, the project seeks to apply imaging mass cytometry to recapitulate the immune cell localization in hundreds of preserved patient tumor samples, retrieving retrospective spatial compartmentalization of immune cells. Furthermore, this project will focus on analysing the correlation between immune cell characteristics with clinical outcomes, with a focus on the association between immune cell spatial localization and immunotherapy outcomes. The significance of this study is that it not only addresses the gap in our knowledge of kidney tumor immune networks, but also correlates specific tumor immune networks with disease progression and survival rate, providing insights into novel immunotherapy designs. Furthermore, this study provides novel diagnostic biomarkers, such as specific immune cell localization patterns that identify patients who will respond to immunotherapies.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
485908
Name
Ma Jiajie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Spatially resolving tumor immune networks at single-cell resolution of ccRCC tumour immune microenvironment
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Clear Cell Renal Cell Carcinoma; Imaging Mass Cytometry; Immune Networks; Immunotherapy; Kidney Cancer; Patient Outcomes; Single-Cell Rna Sequencing; Spatially Resolved Features; Tissue Microarray; Tumor Immune Microenvironment
Abstract
Kidney cancer contributes to over 430,000 new cases and 179,000 deaths annually worldwide. During later stages of the disease, where cancer spreads from kidney to other vital organs, the disease is mostly incurable. Immunotherapy, which harnesses the host immune system to fight cancer, has contributed to a longer survival time in patients with clear cell kidney cancer (the most common subtype of kidney cancer). However, current immunotherapies are relatively ineffective, as only a minority of patients respond to the treatment and benefit from it. Thus, it is urgent to improve immunotherapies for kidney cancer. The proposed research project aims to profile the immune cell subtypes within retrospective kidney tumor samples by analyzing single-cell RNA sequencing data. In addition, the project seeks to apply imaging mass cytometry to recapitulate the immune cell localization in hundreds of preserved patient tumor samples, retrieving retrospective spatial compartmentalization of immune cells. Furthermore, this project will focus on analysing the correlation between immune cell characteristics with clinical outcomes, with a focus on the association between immune cell spatial localization and immunotherapy outcomes. The significance of this study is that it not only addresses the gap in our knowledge of kidney tumor immune networks, but also correlates specific tumor immune networks with disease progression and survival rate, providing insights into novel immunotherapy designs. Furthermore, this study provides novel diagnostic biomarkers, such as specific immune cell localization patterns that identify patients who will respond to immunotherapies.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ma, Jiajie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~